BXP vs CHRS · rev $3.48B vs $223.7M cap
Boston Properties Inc (BXP) versus Coherus BioSciences Inc (CHRS) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
CHRS does not have a complete income-statement cache yet.
BXP currently screens at market cap $12.12B. CHRS currently screens at market cap $223.7M.
Not investment advice. Open the BXP and CHRS stock pages for the full models.
Not investment advice.